Señales en vivo de IMNM | Maximiza tus Ganancias con Getagraph.com

COMPRAR 104462 min ago

@ $22.58

Emitido: 14 feb 2024 @ 14:40

Retorno: -39.18%

Señal anterior: feb 14 - 10:32

Señal anterior: Vender

Retorno: 6.29 %

Live Chart Being Loaded With Signals

Commentary (26 abr 2024 @ 16:00):

Stats
Volumen de hoy	967 464
Volumen promedio	803 233
Capitalización de mercado	586.68M
EPS	$0 ( 2024-03-21 )
Próxima fecha de ganancias	( $0 ) 2024-05-03
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-7.63
ATR14	$0.0190 (0.14%)

Insider Trading

Date	Person	Action	Amount	type
2024-02-20	Horn Kinney	Buy	300 000	Stock option (right to buy)
2024-02-12	Horn Kinney	Buy	0
2024-01-31	Rosett Max	Buy	175 000	Stock option (right to buy)
2024-01-31	Stoneman Sandra G.	Buy	200 000	Stock option (right to buy)
2024-01-02	Lapetina Bob	Sell	0	Common Stock

INSIDER POWER
-15.83
Last 93 transactions
Buy: 3 618 517 \| Sell: 4 251 388

Volumen Correlación

Largo: -0.33 (neutral)

Corto: -0.83 (strong negative)

Signal:(33.86) Neutral

Immunome, Inc. Correlación

10 Correlaciones Más Positivas
TNXP	0.823
MBIO	0.812

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Immunome, Inc. Correlación - Moneda/Commodity

0.16
( neutral )

0.33
( neutral )

0.00
( neutral )

0.23
( neutral )

-0.46
( neutral )

-0.15
( neutral )

Immunome, Inc. Finanzas

Annual	2022
Ingresos:	$0
Beneficio Bruto:	$-631 000 (0.00 %)
EPS:	$-3.09

FY	2022
Ingresos:	$0
Beneficio Bruto:	$-631 000 (0.00 %)
EPS:	$-3.09

FY	2021
Ingresos:	$0.00
Beneficio Bruto:	$0.00 (0.00 %)
EPS:	$-5.63

FY	2020
Ingresos:	$0.00
Beneficio Bruto:	$0.00 (0.00 %)
EPS:	$-5.26

Financial Reports:

No articles found.

Immunome, Inc.

Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product candidate for the treatment of SARS-CoV-2 infections and COVID-19. The company was incorporated in 2006 and is headquartered in Exton, Pennsylvania.